Contexium

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 05 Mar 2027. Budget: 1,500,000 USD. The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment a…

Opportunity overview

Project name
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health logo
National Institutes of Health
Donor
National Institutes of Health

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States
Budget
1,500,000
Currency
US Dollar

Summary

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and...

Frequently asked questions

What is High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)?

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 05 Mar 2027. Budget: 1,500,000 USD. The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment a…

Who is funding High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)?

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) is funded by National Institutes of Health.

When is the deadline to apply for High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)?

The application deadline is 05 Mar 2027 00:00 (UTC).

Where will the High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) project take place?

The project location(s) are: United States.

What is the budget for High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)?

The available budget is 1,500,000 USD.

How can I apply for High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.